Zobrazeno 1 - 10
of 111
pro vyhledávání: '"Sushan Luo"'
Autor:
Huahua Zhong, Li Zeng, Xuefan Yu, Qing Ke, Jihong Dong, Yan Chen, Lijun Luo, Xueli Chang, Junhong Guo, Yiqi Wang, Hui Xiong, Rongrong Liu, Changxia Liu, Jibao Wu, Jie Lin, Jianying Xi, Wenhua Zhu, Song Tan, Fuchen Liu, Jiahong Lu, Chongbo Zhao, Sushan Luo
Publikováno v:
Orphanet Journal of Rare Diseases, Vol 19, Iss 1, Pp 1-9 (2024)
Abstract Background As the most common subtype of adult muscular dystrophy worldwide, large cohort reports on myotonic dystrophy type I (DM1) in China are still lacking. This study aims to analyze the genetic and clinical characteristics of Chinese H
Externí odkaz:
https://doaj.org/article/43cef6e073334a009d68304f552df021
Autor:
Jie Song, Xiao Huan, Yuanyi Chen, Yeting Luo, Huahua Zhong, Yuan Wang, Lei Yang, Caihua Xi, Yu Yang, Jianying Xi, Jianming Zheng, Zongtai Wu, Chongbo Zhao, Sushan Luo
Publikováno v:
Therapeutic Advances in Neurological Disorders, Vol 17 (2024)
Eculizumab has improved recovery from ventilatory support in myasthenic crisis (MC) cases. However, the safety and efficacy profiles from prospective studies are still lacking. This study aimed to explore eculizumab’s safety and efficacy in a prosp
Externí odkaz:
https://doaj.org/article/3b2104cb0774475ebaf6d823628db8aa
Autor:
Jie Song, Haiyan Wang, Xiao Huan, Qilong Jiang, Zongtai Wu, Chong Yan, Jianying Xi, Chongbo Zhao, Huiyu Feng, Sushan Luo
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
IntroductionEfgartigimod is effective and well-tolerated in patients with anti-acetylcholine receptor (AChR) antibody-positive generalized myasthenia gravis (MG). However, the therapeutic potential and the safety profile of efgartigimod in myasthenic
Externí odkaz:
https://doaj.org/article/32bd87e8d6494ba7a6f7117366d52b66
Autor:
Yuan Wang, Xiao Huan, Xinfang Zhu, Jie Song, Chong Yan, Lei Yang, Caihua Xi, Yafang Xu, Jianying Xi, Chongbo Zhao, Rong Xia, Sushan Luo
Publikováno v:
Therapeutic Advances in Neurological Disorders, Vol 17 (2024)
Background: Myasthenic crisis (MC) is a life-threatening condition for myasthenia gravis (MG). Therapeutic plasma exchange (TPE) and intravenous immunoglobulin (IVIg) efficaciously treat patients with MC. However, not every MC responds well to rescue
Externí odkaz:
https://doaj.org/article/31d2211feb514f87ba20413faf12a27f
Autor:
Yongsheng Zheng, Jianian Hu, Chong Sun, Kai Qiao, Yanyin Zhao, Bingyou Liu, Jian Sun, Jianying Xi, Sushan Luo, Jiahong Lu, Chongbo Zhao, Jie Lin
Publikováno v:
Frontiers in Neurology, Vol 15 (2024)
BackgroundRefractory chronic inflammatory demyelinating polyneuropathy (CIDP) is a challenging subset of CIDP. It does not respond well to immune therapy and causes substantial disability. A comprehensive understanding of its clinical profile, electr
Externí odkaz:
https://doaj.org/article/90ba3bb707d444bfa83a668b18a5a16f
Autor:
Huahua Zhong, Xiao Huan, Rui Zhao, Manqiqige Su, Chong Yan, Jie Song, Jianying Xi, Chongbo Zhao, Feifei Luo, Sushan Luo
Publikováno v:
Journal of Translational Medicine, Vol 21, Iss 1, Pp 1-14 (2023)
Abstract Background Myasthenia gravis (MG) is the most prevalent autoimmune disorder affecting the neuromuscular junction. A rapid deterioration in respiratory muscle can lead to a myasthenic crisis (MC), which represents a life-threatening condition
Externí odkaz:
https://doaj.org/article/a4239e1daecf4466ae4bb09be2645a32
Publikováno v:
Frontiers in Neurology, Vol 14 (2023)
ObjectivesThis study aimed to assess the feasibility of a machine learning-based radiomics tools to discriminate between Limb-girdle muscular dystrophy R2 (LGMDR2) and immune-mediated necrotizing myopathy (IMNM) using lower-limb muscle magnetic reson
Externí odkaz:
https://doaj.org/article/c487971b4ea5441cb4c90de83ec2ff00
Autor:
Nanqing Xiong, Weizhuo Liu, Jian Li, Sushan Luo, Wentao Gu, Wenhua Zhu, Jianying Xi, Jie Lin, Bangwei Wu, Xinping Luo
Publikováno v:
Heliyon, Vol 9, Iss 3, Pp e13940- (2023)
Background: Cardiac involvement is commonly present in various neuromuscular diseases which may develop life-threatening consequences. The early manifestation is often asymptomatic which however has been insufficiently studied. Objectives: We aim to
Externí odkaz:
https://doaj.org/article/b9aa19c5a329444abbf4bb942121f421
Autor:
Xiao Huan, Rui Zhao, Jie Song, Huahua Zhong, Manqiqige Su, Chong Yan, Ying Wang, Sheng Chen, Zhirui Zhou, Jiahong Lu, Jianying Xi, Sushan Luo, Chongbo Zhao
Publikováno v:
BMC Immunology, Vol 23, Iss 1, Pp 1-9 (2022)
Abstract Background Myasthenia gravis (MG) is an autoimmune disorder affecting neuromuscular junctions. Cytokines play important roles in facilitating the immune response and augmenting the pathogenic antibody production. The current study aims to se
Externí odkaz:
https://doaj.org/article/2eadf365c5154810bd9e947fc185bffd
Autor:
Huahua Zhong, Zhe Ruan, Chong Yan, Zhiguo Lv, Xueying Zheng, Li-Ying Goh, Jianying Xi, Jie Song, Lijun Luo, Lan Chu, Song Tan, Chao Zhang, Bitao Bu, Yuwei Da, Ruisheng Duan, Huan Yang, Sushan Luo, Ting Chang, Chongbo Zhao
Publikováno v:
Therapeutic Advances in Neurological Disorders, Vol 16 (2023)
Background: Myasthenia gravis (MG) is an autoimmune disease characterized by muscle weakness and fatigability. The fluctuating nature of the disease course impedes the clinical management. Objective: The purpose of the study was to establish and vali
Externí odkaz:
https://doaj.org/article/92d4c16e43ef4257a36b9b8b7366c27e